CI Mobility 02, a Series of CIM Funds, LLC, has announced a new private offering under Rule 506(b) of the Securities Act. This filing is significant as it indicates the company's strategy to raise funds through private investment, a common method in the investment fund industry.
Founded in 2026 and based in New York, CI Mobility 02 operates as a pooled investment fund. The company is structured as a limited liability company and is incorporated in Delaware. Its recent filing on October 29, 2026, is a Form D, which is typically used for private placements.
The filing states that the company aims to raise a total of $4,988,815, of which it has already secured $1,424,275 from 16 investors. The minimum investment accepted is set at $50,000. The offering is designed to attract accredited investors, as indicated by the lack of non-accredited investors in the current round.
"CI Mobility 02, a Series of CIM Funds, LLC, is raising funds through a private offering to enhance its investment capabilities," the filing notes.
The filing also mentions that the total offering amount is significant for the company and reflects a growing trend in the pooled investment fund sector. With an increasing number of firms opting for private placements, this move may position CI Mobility 02 favorably among its peers.
In terms of sales compensation, the company has reported a total of $64,467 in sales commissions, with no finder’s fees involved. The sales are being managed by Clarity Capital Limited, located in British Columbia, Canada, which is authorized to solicit investments across all states.
Looking ahead, the filing does not specify what happens next for CI Mobility 02, but the company is likely to continue its efforts to secure the remaining funds in the offering.
Read Next
Workers United Files to Sell $8.4 Million in Amalgamated Stock
Carvana Co. files to sell 10 million shares of stock
Platford Giles Richard to Sell 55,617 Takeda Shares
Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations
Kiniksa Pharmaceuticals reports significant stock sale by officer
Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals










